Dr. Michael McCollum
Claim this profileVirginia Oncology Associates
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
8 reported clinical trials
15 drugs studied
Area of expertise
1Ovarian Cancer
Stage III
Stage IV
BRCA positive
2Fallopian Tube Cancer
Stage III
Stage IV
BRCA positive
Affiliated Hospitals
Clinical Trials Michael McCollum is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
ZN-c3
for Serous Carcinoma
This is a multi-part Phase 2 study to evaluate the efficacy and safety of azenosertib (ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the study will be conducted in subjects whose tumors are Cyclin E1 positive as determined by central review using the Sponsor's investigational clinical trial assay.
Recruiting1 award Phase 21 criteria
More about Michael McCollum
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael McCollum has experience with
- Paclitaxel
- Mirvetuximab Soravtansine
- Irinotecan
- Topotecan
- Tisotumab Vedotin
- Vinorelbine
Breakdown of trials Michael McCollum has run
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Neoplasm
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael McCollum specialize in?
Michael McCollum focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage III patients, or patients who are Stage IV.
Is Michael McCollum currently recruiting for clinical trials?
Yes, Michael McCollum is currently recruiting for 2 clinical trials in Norfolk Virginia. If you're interested in participating, you should apply.
Are there any treatments that Michael McCollum has studied deeply?
Yes, Michael McCollum has studied treatments such as Paclitaxel, Mirvetuximab Soravtansine, Irinotecan.
What is the best way to schedule an appointment with Michael McCollum?
Apply for one of the trials that Michael McCollum is conducting.
What is the office address of Michael McCollum?
The office of Michael McCollum is located at: Virginia Oncology Associates, Norfolk, Virginia 23502 United States. This is the address for their practice at the Virginia Oncology Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.